Healthy male/female adults
Conditions
Interventions
Consume 3g of the test food every day for 6 weeks.
Sponsors
Toei Shinyaku Co.,Ltd.
1)SheepMedical Co.,Ltd. 2)Laboratory for Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Males and females aged more than or equal to 20, and less than 60 when obtaining the consent.
Exclusion criteria
Exclusion criteria: 1)Subjects who are regularly consuming food or supplement containing beta-glucan which is the active ingredient of test food. 2)Subjects under treatment which would affects the trial results. 3) Subjects who do not carry out the inspection including collecting saliva and stool samples under the test rule. 4) Subjects with chronic diarrhea symptoms. 5) Subjects who have current medical history/anamnesis of severe diabetes, hepatic, renal, hypertension, cardiac, hepatic, glucose tolerance diseases. 6)Subjects who would be allergic to test foods. 7)Subjects who want to pregnancy, pregnant, possibly pregnant, or lactating women. 8)Subjects who are participating or have been participated to other clinical tests with specific medicine/food within the last 4 weeks before this trial, or planning to join those after giving informed consent. 9)Subjects who take excessive alcohol or subjects with irregular dietary habits. 10)Subjects who have a plan or who have taken antibiotics within 3 months prior to the trial. 11)Subjects who have a plan or who have taken medication which would affect the trial result (e.g. drugs for intestinal disorder, and laxative) within 2 weeks prior to the trial. 12)Subjects who have removed tonsils and/or appendix. 13)Subjects who have received the surgery which would affect the trial result (e.g. colonoscopy, removal of gallstones and/or gall bladder, or gastric bypass surgery) within half a year before obtaining the consent. 14)Subjects who would encounter a dramatic change in their living environment (e.g. relocation, job-changing). 15)Others who have been determined ineligible by principal investigator or cooperating institution.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intestinal microbiome | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Oral microbiome 2.Defecation status 3.Body weight, BMI, Waist size 4.SF36v2 Japanese version | — |
Countries
Japan
Contacts
Public ContactAkitomo Motoi
Toei Shinyaku Co.,Ltd. President
Outcome results
None listed